Cargando…
Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma
BACKGROUND: Circulating tumor cells (CTC) shows great prospect to realize precision medicine in cancer patients. METHODS: We developed the NanoVelcro Chip integrating three functional mechanisms. NanoVelcro CTC capture efficiency was tested in stage III or IV lung adenocarcinoma. Further, ALK-rearra...
Autores principales: | He, Weiling, Xu, Di, Wang, Zhuo, Wu, Hui, Xiang, Xianhong, Tang, Bing, Jiang, Wenting, Cui, Yongmei, Wang, Han, Jiang, Neng, Sun, Yu, Chen, Yangshan, Li, Shuhua, Hou, Minzhi, Zhang, Yang, Wang, Liantang, Ke, Zun-fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339314/ https://www.ncbi.nlm.nih.gov/pubmed/30658713 http://dx.doi.org/10.1186/s12967-019-1779-5 |
Ejemplares similares
-
CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9
por: He, Weiling, et al.
Publicado: (2018) -
Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report
por: WANG, YUE FENG, et al.
Publicado: (2014) -
Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma
por: He, Weiling, et al.
Publicado: (2018) -
Polymer nanofiber-based microchips for EGFR mutation analysis of circulating tumor cells in lung adenocarcinoma
por: Jiang, Wenting, et al.
Publicado: (2018) -
Overcoming T790M mutant small cell lung cancer with the third‐generation EGFR‐TKI osimertinib
por: Tang, Kejing, et al.
Publicado: (2018)